Rockville, Maryland - May 14, 2026 - MacroGenics, Inc., a biopharmaceutical company specializing in developing antibody-based therapies for cancer treatment, shared news that its President and CEO, Eric Risser, will engage in a fireside chat at the Stifel 2026 Virtual Targeted Oncology Forum on May 20, 2026, at 10:30 a.m. ET. The event aims to provide insights on innovative cancer treatments. MacroGenics, Inc. is listed on Nasdaq as MGNX, catering to developing groundbreaking therapies. This forum signifies a pivotal opportunity for the company's leadership to discuss its strategies and advancements in the field of oncology.